Correction to: Leukemia (2017) 31, 203–213; doi:10.1038/leu.2016.174
Following the online publication of this article, the authors noted that the name of the first author was abbreviated incorrectly in the author list. The complete and correct author names appear above.
The online version of the original article can be found at 10.1038/leu.2016.174
About this article
Cite this article
Ishiyama, K., Kitawaki, T., Sugimoto, N. et al. Erratum: Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib. Leukemia 31, 268 (2017). https://doi.org/10.1038/leu.2016.188
Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection
Frontiers in Pharmacology (2019)